QIAGEN Acquires Ingenuity Systems
Thursday, May 02, 2013
Suite of web-based applications powered by a unique expert-curated Knowledge Base eases major bottlenecks to leveraging genomic data in research and clinical diagnostics.
NextBio Announces Translational Medicine Partnership with Sanofi
Thursday, May 02, 2013
Multi-year collaboration with Sanofi aimed at using NextBio Clinical platform.
Study Establishes Basis for Genomic Classification of Endometrial Cancers
Thursday, May 02, 2013
Proper categorization is important for choosing the best treatment.
Physicists, Biologists Unite to Expose How Cancer Spreads
Thursday, May 02, 2013
New study has found that cancer cells that can break out of a tumor are more aggressive and nimble than nonmalignant cells.
Genemarkers Sponsors Rare Disease Challenge
Thursday, May 02, 2013
Genemarkers to sponsor the Rare Disease Science Challenge: Be HEARD (Helping Empower and Accelerate Research Discoveries) and work with Lori Silveira at National Jewish Health on her research project.
Dana-Farber’s Belfer Institute for Applied Cancer Science and Evotec Collaborate
Wednesday, May 01, 2013
Research collaboration aimed at discovering and commercialising novel cancer treatments based on epigenetic drug mechanisms.
Teva Expands Management Team
Wednesday, May 01, 2013
Teva Pharmaceutical Industries Ltd. announced that Paul J. Sekhri has been appointed Group Executive Vice President, Global Business Development and Chief Strategy Officer.
FORMA Therapeutics and Celgene Corporation Establish Broad Strategic Collaboration
Wednesday, May 01, 2013
FORMA and Celgene will discover, develop and commercialize drug candidates to regulate protein homeostasis targets.
Celator® Pharmaceuticals Raises $32.5 Million Completing a $39.3 Million Private Placement Financing
Wednesday, May 01, 2013
Proceeds will support phase 3 study of CPX-351 in acute myeloid leukemia.
|
|
|
|
|
|
